Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -1.48 Million USD | -46.52% |
| 2019 | -1.01 Million USD | 17.8% |
| 2018 | -1.23 Million USD | 19.26% |
| 2017 | -1.52 Million USD | 80.58% |
| 2016 | -7.85 Million USD | -193405.66% |
| 2015 | -4057.77 USD | 99.22% |
| 2014 | -518.03 Thousand USD | -6.02% |
| 2013 | -488.61 Thousand USD | -20.15% |
| 2012 | -406.68 Thousand USD | 98.53% |
| 2011 | -27.59 Million USD | -1642.11% |
| 2010 | -1.58 Million USD | -330.74% |
| 2009 | -367.69 Thousand USD | 96.95% |
| 2008 | -12.06 Million USD | -611.24% |
| 2007 | -1.69 Million USD | -44.26% |
| 2006 | -1.17 Million USD | -23.09% |
| 2005 | -955.45 Thousand USD | -44.24% |
| 2004 | -662.41 Thousand USD | 0.0% |
| 2002 | -494.74 Thousand USD | 15.65% |
| 2001 | -586.51 Thousand USD | -210.34% |
| 2000 | -188.99 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -25.84 Thousand USD | 93.36% |
| 2021 Q1 | -269.13 Thousand USD | -12.47% |
| 2021 Q2 | -389.41 Thousand USD | -44.69% |
| 2021 FY | - USD | 100.0% |
| 2020 Q4 | -239.28 Thousand USD | 25.16% |
| 2020 Q1 | -69.89 Thousand USD | 89.54% |
| 2020 Q2 | -853.71 Thousand USD | -1121.46% |
| 2020 Q3 | -319.73 Thousand USD | 62.55% |
| 2020 FY | -1.48 Million USD | -46.52% |
| 2019 Q2 | 61.97 Thousand USD | 154.01% |
| 2019 FY | -1.01 Million USD | 17.8% |
| 2019 Q1 | -114.74 Thousand USD | 62.53% |
| 2019 Q3 | -291.2 Thousand USD | -569.87% |
| 2019 Q4 | -667.94 Thousand USD | -129.37% |
| 2018 FY | -1.23 Million USD | 19.26% |
| 2018 Q4 | -306.2 Thousand USD | 46.46% |
| 2018 Q3 | -571.95 Thousand USD | -159.73% |
| 2018 Q2 | -220.2 Thousand USD | -65.91% |
| 2018 Q1 | -132.72 Thousand USD | 85.77% |
| 2017 Q2 | -1.01 Million USD | 15.97% |
| 2017 Q1 | -1.21 Million USD | 22.41% |
| 2017 FY | -1.52 Million USD | 80.58% |
| 2017 Q4 | -932.82 Thousand USD | -156.84% |
| 2017 Q3 | 1.64 Million USD | 260.95% |
| 2016 Q1 | -3.74 Million USD | -3662.14% |
| 2016 Q4 | -1.56 Million USD | -21.68% |
| 2016 FY | -7.85 Million USD | -193405.66% |
| 2016 Q3 | -1.28 Million USD | -2.05% |
| 2016 Q2 | -1.25 Million USD | 66.35% |
| 2015 Q4 | -99.49 Thousand USD | -608.98% |
| 2015 Q1 | -46.26 Thousand USD | -37.79% |
| 2015 Q3 | -14.03 Thousand USD | 61.14% |
| 2015 FY | -4057.77 USD | 99.22% |
| 2015 Q2 | -36.11 Thousand USD | 21.93% |
| 2014 Q3 | -31.42 Thousand USD | 92.38% |
| 2014 FY | -518.03 Thousand USD | -6.02% |
| 2014 Q1 | -363.55 Thousand USD | -671.17% |
| 2014 Q2 | -412.15 Thousand USD | -13.37% |
| 2014 Q4 | -33.57 Thousand USD | -6.84% |
| 2013 Q3 | -39.58 Thousand USD | -4.03% |
| 2013 Q2 | -38.05 Thousand USD | 76.98% |
| 2013 Q4 | -47.14 Thousand USD | -19.08% |
| 2013 Q1 | -165.28 Thousand USD | -132.29% |
| 2013 FY | -488.61 Thousand USD | -20.15% |
| 2012 FY | -406.68 Thousand USD | 98.53% |
| 2012 Q4 | -71.15 Thousand USD | 24.17% |
| 2012 Q3 | -93.83 Thousand USD | -34.66% |
| 2012 Q2 | -69.68 Thousand USD | 99.52% |
| 2012 Q1 | -14.63 Million USD | -15.65% |
| 2011 Q1 | -836.1 Thousand USD | -379.83% |
| 2011 Q2 | -220.73 Thousand USD | 73.6% |
| 2011 FY | -27.59 Million USD | -1642.11% |
| 2011 Q4 | -12.65 Million USD | -13357.78% |
| 2011 Q3 | -94.05 Thousand USD | 57.39% |
| 2010 Q4 | -174.24 Thousand USD | 70.52% |
| 2010 FY | -1.58 Million USD | -330.74% |
| 2010 Q2 | 30.76 Thousand USD | 118.24% |
| 2010 Q3 | -591.05 Thousand USD | -2021.07% |
| 2010 Q1 | -168.72 Thousand USD | -261.7% |
| 2009 FY | -367.69 Thousand USD | 96.95% |
| 2009 Q1 | -7.1 Million USD | -114.42% |
| 2009 Q2 | -675.78 Thousand USD | 90.49% |
| 2009 Q3 | 441.44 Thousand USD | 165.32% |
| 2009 Q4 | 104.34 Thousand USD | -76.36% |
| 2008 FY | -12.06 Million USD | -611.24% |
| 2008 Q4 | -3.31 Million USD | -380.03% |
| 2008 Q1 | -819.35 Thousand USD | -515.54% |
| 2008 Q3 | -690.53 Thousand USD | 31.56% |
| 2008 Q2 | -1 Million USD | -23.13% |
| 2007 Q1 | -615.02 Thousand USD | -3377.68% |
| 2007 FY | -1.69 Million USD | -44.26% |
| 2007 Q3 | -375.55 Thousand USD | 35.04% |
| 2007 Q4 | 197.17 Thousand USD | 152.5% |
| 2007 Q2 | -578.13 Thousand USD | 6.0% |
| 2006 FY | -1.17 Million USD | -23.09% |
| 2006 Q1 | -489.22 Thousand USD | -263.07% |
| 2006 Q2 | -260.14 Thousand USD | 46.83% |
| 2006 Q3 | -308.85 Thousand USD | -18.73% |
| 2006 Q4 | 18.76 Thousand USD | 106.08% |
| 2005 FY | -955.45 Thousand USD | -44.24% |
| 2005 Q2 | -237.76 Thousand USD | -4.44% |
| 2005 Q3 | -79.8 Thousand USD | 66.43% |
| 2005 Q4 | -134.74 Thousand USD | -68.84% |
| 2005 Q1 | -227.66 Thousand USD | -82.39% |
| 2004 Q3 | -218.15 Thousand USD | -185.92% |
| 2004 Q2 | -76.29 Thousand USD | 52.52% |
| 2004 Q1 | -160.69 Thousand USD | -183.69% |
| 2004 Q4 | -124.82 Thousand USD | 42.78% |
| 2004 FY | -662.41 Thousand USD | 0.0% |
| 2003 Q1 | -11.85 Thousand USD | 35.54% |
| 2003 Q4 | -56.64 Thousand USD | -104.29% |
| 2003 Q2 | -444.69 Thousand USD | -3652.19% |
| 2003 Q3 | -27.72 Thousand USD | 93.76% |
| 2002 Q3 | -20.41 Thousand USD | 95.89% |
| 2002 Q4 | -18.38 Thousand USD | 9.93% |
| 2002 Q1 | -20.86 Thousand USD | 57.21% |
| 2002 Q2 | -496.66 Thousand USD | -2280.37% |
| 2002 FY | -494.74 Thousand USD | 15.65% |
| 2001 FY | -586.51 Thousand USD | -210.34% |
| 2001 Q3 | -21.75 Thousand USD | 0.0% |
| 2001 Q4 | -48.76 Thousand USD | -124.19% |
| 2000 FY | -188.99 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | -722.81 Thousand USD | 100.0% |
| IR-Med Inc. | -4.9 Million USD | 100.0% |
| Polarean Imaging plc | -11.88 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 100.0% |
| Avitar, Inc. | -2.25 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.16 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 58.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.51 Million USD | 100.0% |
| QHSLab, Inc. | -468.36 Thousand USD | 100.0% |
| Wellstar International, Inc. | -3.1 Million USD | 100.0% |
| Össur hf. | 58.38 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 100.0% |
| Escalon Medical Corp. | -125.26 Thousand USD | 100.0% |
| Aurora Spine Corporation | -1.68 Million USD | 100.0% |
| BrainsWay Ltd. | -4.19 Million USD | 100.0% |
| NewCardio, Inc. | -11.49 Million USD | 100.0% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 100.0% |
| Vivos Inc. | -2.89 Million USD | 100.0% |
| MicroPort Scientific Corporation | -477.62 Million USD | 100.0% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 100.0% |
| Nanomix Corporation | -12.33 Million USD | 100.0% |
| Theraclion SA | -3.67 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 100.0% |
| Positron Corporation | -1.63 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 100.0% |
| Lombard Medical, Inc. | -31.03 Million USD | 100.0% |
| ALR Technologies Inc. | -11.89 Million USD | 100.0% |
| Stratec SE | 14.42 Million USD | 100.0% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -13.32 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 46.44 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 100.0% |
| Ingen Technologies, Inc. | -5.06 Million USD | 100.0% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 100.0% |
| United American Healthcare Corporation | 723 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -3.61 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 100.0% |
| Urologix, Inc. | -7.6 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 100.0% |
| SS Innovations International, Inc. | -20.94 Million USD | 100.0% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 100.0% |
| Smith & Nephew plc | 263 Million USD | 100.0% |
| NIOX Group Plc | 13.64 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.45 Million USD | 100.0% |
| Broncus Holding Corporation | -28.09 Million USD | 100.0% |
| Brain Scientific Inc. | -12.34 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 100.0% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 100.0% |